Korsana Biosciences Appoints Mark Vignola, Ph.D., as Chief Financial Officer
Proven leader with over 15 years of experience successfully implementing financial and operational strategies across biotech industry WALTHAM, Mass.–(BUSINESS WIRE)–Korsana Biosciences, Inc. (“Korsana” or the “Company”), a biotechnology company discovering and developing novel therapies to reduce the burden of neurodegenerative diseases, today announced that Mark Vignola, Ph.D., has joined as Chief Financial Officer (CFO). Dr. … [Read more…]
